HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 368 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Capital Management, Inc | 21 | $757 | 0.00% |
| Twin Tree Management, LP | 1,639 | $59,119 | 0.00% |
| Rosenberg Matthew Hamilton | 1 | $36 | 0.00% |
| SJS Investment Consulting Inc. | 20 | $722 | 0.00% |
| NewSquare Capital LLC | 35 | $1,262 | 0.00% |
| Disciplined Investments, LLC | 16 | $577 | 0.00% |
| D. E. Shaw & Co., Inc. | 11,200 | $403,984 | 0.00% |
| Allworth Financial LP | 1,119 | $40,363 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 42 | $1,515 | 0.00% |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 190 | $7,000 | 0.00% |
| BESSEMER GROUP INC | 807 | $29 | 0.00% |
| SRS Capital Advisors, Inc. | 31 | $1,119 | 0.00% |
| M&R CAPITAL MANAGEMENT INC | 32 | $1,154 | 0.00% |
| Baker Avenue Asset Management, LP | 7 | $252 | 0.00% |
| Clearstead Advisors, LLC | 78 | $2,814 | 0.00% |
| AdvisorNet Financial, Inc | 16 | $577 | 0.00% |
| Amundi | 15,649 | $577,135 | 0.00% |
| Citadel Advisors | 31,000 | $1,118,170 | 0.00% |
| Citadel Advisors | 13,400 | $483,338 | 0.00% |
| Steward Partners Investment Advisory, LLC | 300 | $10,821 | 0.00% |
External links
This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.